Why this advisor has been buying Colgate and trimming Novo N

Katherine Owen, portfolio manager at Mackenzie Investments, says selling Novo Nordisk - the company behind popular weight-loss drugs - has been for ‘risk management’ in her portfolios

Related Keywords

Canada , Toronto , Ontario , Katherine Owen , Darren Mckiernan , Dupont , Broadcom Inc , Jpmorgan Chase Co , Palmolive Co , Mackenzie Global Dividend Fund , Novo Nordisk , Microsoft Corp , Log Increate Free , Globe Advisor , Mackenzie Investments , Irish Spring , Speed Stick , Adveditorial , Appwebview , Brenda Bouw , Advisor Noregwall , Scent , Company , Stock , Business , United States , Return , Plumbing , Fund , Colgate Palmolive Co ,